|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brown S, Banfill K, Aznar MC, Whitehurst P
and Faivre Finn C: The evolving role of radiotherapy in non-small
cell lung cancer. Br J Radiol. 92:201905242019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang Q, Tang Y, Tang C, Cong H, Wang X,
Shen X and Ju S: Diminished LINC00173 expression induced miR-182-5p
accumulation promotes cell proliferation, migration and apoptosis
inhibition via AGER/NF-κB pathway in non-small-cell lung cancer. Am
J Transl Res. 11:4248–4262. 2019.PubMed/NCBI
|
|
4
|
Duma N, Santana-Davila R and Molina JR:
Non-small cell lung cancer: Epidemiology, screening, diagnosis, and
treatment. Mayo Clin Proc. 94:1623–1640. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li N, Zhao J, Ma Y, Roy B, Liu R,
Kristiansen K and Gao Q: Dissecting the expression landscape of
mitochondrial genes in lung squamous cell carcinoma and lung
adenocarcinoma. Oncol Lett. 16:3992–4000. 2018.PubMed/NCBI
|
|
6
|
Faruki H, Mayhew GM, Serody JS, Hayes DN,
Perou CM and Lai-Goldman M: Lung adenocarcinoma and squamous cell
carcinoma gene expression subtypes demonstrate significant
differences in tumor immune landscape. J Thorac Oncol. 12:943–953.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomasini P, Khobta N, Greillier L and
Barlesi F: Ipilimumab: Its potential in non-small cell lung cancer.
Ther Adv Med Oncol. 4:43–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paez JG, Jänne PA, Lee JC, Tracy S,
Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, et
al: EGFR mutations in lung cancer: Correlation with clinical
response to gefitinib therapy. Science. 304:1497–1500. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Y, Liu H, Shi X, Yao Y, Yang W and Song
Y: The long non-coding RNA HNF1A-AS1 regulates proliferation and
metastasis in lung adenocarcinoma. Oncotarget. 6:9160–9172. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long Non-Coding RNA in the pathogenesis of cancers. Cells.
8:10152019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tasharrofi B and Ghafouri-Fard S: Long
Non-coding RNAs as regulators of the mitogen-activated protein
kinase (MAPK) pathway in cancer. Klin Onkol. 31:95–102. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei L, Yi Z, Guo K and Long X: Long
noncoding RNA BCAR4 promotes glioma cell proliferation via
EGFR/PI3K/AKT signaling pathway. J Cell Physiol. 234:23608–23617.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su Y, Lu J, Chen X, Liang C, Luo P, Qin C
and Zhang J: Long non-coding RNA HOTTIP affects renal cell
carcinoma progression by regulating autophagy via the
PI3K/Akt/Atg13 signaling pathway. J Cancer Res Clin Oncol.
145:573–588. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghafouri-Fard S, Abak A, Tondro Anamag F,
Shoorei H, Majidpoor J and Taheri M: The emerging role of
non-coding RNAs in the regulation of PI3K/AKT pathway in the
carcinogenesis process. Biomed Pharmacother. 137:1112792021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen DQ, Zheng XD, Cao Y, He XD, Nian WQ,
Zeng XH and Liu XY: Long non-coding RNA LINC00628 suppresses the
growth and metastasis and promotes cell apoptosis in breast cancer.
Eur Rev Med Pharmacol Sci. 21:275–283. 2017.PubMed/NCBI
|
|
17
|
Zhang MC, Zhang L, Zhang MQ, Yang GX, Wang
FZ and Ding P: Downregulated LINC00628 aggravates the progression
of colorectal cancer via inhibiting p57 level. Eur Rev Med
Pharmacol Sci. 24:1763–1770. 2020.PubMed/NCBI
|
|
18
|
Tian Y, Yu M, Sun L, Liu L, Wang J, Hui K,
Nan Q, Nie X, Ren Y and Ren X: Distinct patterns of mRNA and lncRNA
expression differences between lung squamous cell carcinoma and
adenocarcinoma. J Comput Biol. 27:1067–1078. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu M, Tian Y, Wu M, Gao J, Wang Y, Liu F,
Sheng S, Huo S and Bai J: A comparison of mRNA and circRNA
expression between squamous cell carcinoma and adenocarcinoma of
the lungs. Genet Mol Biol. 43:e202000542020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu SF, Zheng Y, Zhang L, Wang P, Niu CM,
Wu T, Tian Q, Yin XB, Shi SS, Zheng L and Gao LM: Long Non-coding
RNA LINC00628 interacts epigenetically with the LAMA3 promoter and
contributes to lung adenocarcinoma. Mol Ther Nucleic Acids.
18:166–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu S, Zheng Q, Xiong J, Wu H, Wang W and
Zhou W: Long non-coding RNA MVIH promotes cell proliferation,
migration, invasion through regulating multiple cancer-related
pathways, and correlates with worse prognosis in pancreatic ductal
adenocarcinomas. Am J Transl Res. 12:2118–2135. 2020.PubMed/NCBI
|
|
23
|
Wang Y, Ding X, Hu H, He Y, Lu Z, Wu P,
Tian L, Xia T, Yin J, Yuan H, et al: Long non-coding RNA lnc-PCTST
predicts prognosis through inhibiting progression of pancreatic
cancer by downregulation of TACC-3. Int J Cancer. 143:3143–3154.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng J, Li J, Qie P, Li Z, Xu Y and Tian
Z: Long non-coding RNA (lncRNA) PGM5P4-AS1 inhibits lung cancer
progression by up-regulating leucine zipper tumor suppressor
(LZTS3) through sponging microRNA miR-1275. Bioengineered.
12:196–207. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu W, Sun Z, Yang L, Han Y, Yue L, Deng L
and Yao R: lncRNA PTAR promotes NSCLC cell proliferation, migration
and invasion by sponging microRNA-101. Mol Med Rep. 20:4168–4174.
2019.PubMed/NCBI
|
|
26
|
Chen Z, Chen X, Lei T, Gu Y, Gu J, Huang
J, Lu B, Yuan L, Sun M and Wang Z: Integrative analysis of NSCLC
identifies LINC01234 as an oncogenic lncRNA that interacts with
HNRNPA2B1 and regulates miR-106b biogenesis. Mol Ther.
28:1479–1493. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He R, Wu JX, Zhang Y, Che H and Yang L:
LncRNA LINC00628 overexpression inhibits the growth and invasion
through regulating PI3K/Akt signaling pathway in osteosarcoma. Eur
Rev Med Pharmacol Sci. 22:5857–5866. 2018.PubMed/NCBI
|
|
28
|
Zhang ZZ, Zhao G, Zhuang C, Shen YY, Zhao
WY, Xu J, Wang M, Wang CJ, Tu L, Cao H and Zhang ZG: Long
non-coding RNA LINC00628 functions as a gastric cancer suppressor
via long-range modulating the expression of cell cycle related
genes. Sci Rep. 6:274352016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song JY, Li XP, Qin XJ, Zhang JD, Zhao JY
and Wang R: A fourteen-lncRNA risk score system for prognostic
prediction of patients with non-small cell lung cancer. Cancer
Biomark. 29:493–508. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmidt LH, Spieker T, Koschmieder S,
Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, et al: The long noncoding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA linc00673
regulated non-small cell lung cancer proliferation, migration,
invasion and epithelial mesenchymal transition by sponging
miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Navarro A, Moises J, Santasusagna S,
Marrades RM, Viñolas N, Castellano JJ, Canals J, Muñoz C, Ramírez
J, Molins L and Monzo M: Clinical significance of long non-coding
RNA HOTTIP in early-stage non-small-cell lung cancer. BMC Pulm Med.
19:552019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shinmura K, Igarashi H, Kato H, Kawanishi
Y, Inoue Y, Nakamura S, Ogawa H, Yamashita T, Kawase A, Funai K and
Sugimura H: CLCA2 as a novel immunohistochemical marker for
differential diagnosis of squamous cell carcinoma from
adenocarcinoma of the lung. Dis Markers. 2014:6192732014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Castro J, Rodríguez MC,
Martínez-Zorzano VS, Sánchez-Rodríguez P and Sánchez-Yagüe J:
Erythrocyte fatty acids as potential biomarkers in the diagnosis of
advanced lung adenocarcinoma, lung squamous cell carcinoma, and
small cell lung cancer. Am J Clin Pathol. 142:111–120. 2014.
View Article : Google Scholar : PubMed/NCBI
|
